Medicine & Life Sciences

1. Mucopolysaccharidosis I 100%
2. Mucopolysaccharidosis II 44%
3. Mucopolysaccharidoses 39%
4. Gangliosidoses 33%
5. Longitudinal Studies 26%
6. TimeLine 25%
7. Caregivers 24%
8. Enzyme Replacement Therapy 18%
9. Mucopolysaccharidosis VI 15%
10. Mucopolysaccharidosis III 15%
11. Phenotype 15%
12. Adrenoleukodystrophy 14%
13. Distance Education 13%
14. Corpus Callosum 13%
15. Hematopoietic Stem Cell Transplantation 13%
16. Emotional Adjustment 12%
17. Enzymes 12%
18. Learning 11%
19. GM2 Gangliosidosis 10%
20. Erythropoietin 10%
21. GM1 Gangliosidosis 10%
22. Natural History 10%
23. Child 9%
24. Transplants 9%
25. Parents 8%
26. Therapeutics 8%
27. miglustat 8%
28. Cognitive Dysfunction 8%
29. Quality of Life 8%
30. Language 7%
31. Cerebrospinal Fluid 7%
32. Neurodegenerative Diseases 7%
33. Pandemics 6%
34. Health Care Outcome Assessment 6%
35. Iduronidase 6%
36. Placebos 6%
37. Randomized Controlled Trials 6%
38. Biomarkers 6%
39. Aptitude 6%
40. Blood Pressure 6%
41. Video Recording 6%
42. Brain 5%
43. Walking 5%
44. Gestational Age 5%
45. Mutation 5%
46. Sandhoff Disease 5%
47. Central Nervous System 5%
48. Kidney 5%
49. Tay-Sachs Disease 5%